Home › Funds › MPM BioImpact LLC › CRBP
MPM BioImpact LLC position in CRBP
CORBUS PHARMACEUTICALS HLDGS · Health Care
MPM BioImpact LLC reported holding 1,667,272 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.88% of its reported portfolio and ranking #34 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's CRBP position evolved
MPM BioImpact LLC first disclosed a stake in CRBP in Q3 2026 at 1,667,272 shares (US$11.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.67M | $11.37M | New |
About CRBP and 13F data
CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 25 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$16.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRBP
- Cormorant Asset Management, LP 2.34M sh · $15.99M · Q3 2026
- Jones Hill Capital LP 886.43K sh · $6.05M · Q3 2026
- DIADEMA PARTNERS LP 800.00K sh · $5.46M · Q3 2026
- Sio Capital Management, LLC 766.36K sh · $5.23M · Q3 2026
- Exome Asset Management LLC 190.71K sh · $1.30M · Q3 2026
- Prosight Management, LP 168.38K sh · $1.15M · Q3 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held CRBP?
MPM BioImpact LLC has disclosed CRBP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is MPM BioImpact LLC's current position in CRBP?
As of Q3 2026, MPM BioImpact LLC holds 1.67M shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $11.37M, representing 0.88% of its reported portfolio and ranking #34.
Has MPM BioImpact LLC been buying or selling CRBP?
In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in CRBP.
Which other funds hold CRBP?
Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.